Determination of 9-nitrocamptothecin by precolumn derivatization and its metabolite 9-aminocamptothecin in a biological fluid using reversed-phase high-performance liquid chromatography with fluorescence detection

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 795, Issue 2, 2003, Pages 309-318

  Zhang, Junhong ^a   Burke, Thomas G ^a   Latus, Lori J ^a  

^a Tigen Pharmaceuticals Inc   (United States)

Author keywords

9 Aminocamptothecin; 9 Nitrocamptothecin; Derivatization, LC

Indexed keywords

BIOLOGICAL MATERIALS; DRUG PRODUCTS; FLUORESCENCE;

FLUORESCENCE DETECTION;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

9 AMINOCAMPTOTHECIN; RUBITECAN;

ARTICLE; BODY FLUID; CHROMATOGRAPHY; DOG; DRUG DETERMINATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLITE; NONHUMAN; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CANIS FAMILIARIS;

EID: 0141761199     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(03)00599-3     Document Type: Article

References (19)

1. Jaxel C., Kohn K.W., Wani M.C., Wall M.E., Pommier Y. Cancer Res. 49:1989;1465.
2. Pantazis P., Early J.A., Kozielski A.J., Mendoza J.T., Hinz H.R., Giovanella B.C. Cancer Res. 53:1993;1577.
3. Pantazis P., Mendoza J.T., Early J.A., Kozielski A.J., Natelson E.A., Giovanella B.C. Eur. J. Haematol. 50:1993;81.
4. Pantazis P., Kozielski A., Rodriguez R., Petry E., Wani M., Wall M., Giovanella B. Melanoma Res. 4:1994;5.
5. Liehr J.G., Ahmed A.E., Giovanella B.C. Ann. N.Y. Acad. Sci. 803:1996;157.
6. Natelson E.A., Giovanella B.C., Verschraegen C.F., Fehir K.M., De Ipolyi P.D., Harris N., Stehlin J.S. Ann. N.Y. Acad. Sci. 803:1996;224.
7. Verschraegen C.F., Natelson E.A., Giovanella B.C., Kavanagh J.J., Kudelka A.P., Freedman R.S., Edwards C.L., Ende K., Stehlin J.S. Anticancer Drugs. 9:1998;36.
8. Stehlin J.S., Giovanella B.C., Natelson E.A., De Ipolyi P.D., Coil D., Davis B., Wolk D., Wallace P., Trojacek A. Int. J. Oncol. 14:1999;821.
9. Verschraegen C.F., Gupta E., Loyer E., Kavanagh J.J., Kudelka A.P., Freedman R.S., Edwards C.L., Harris N., Steger M., Steltz V., Giovanella B.C., Stehlin J.S. Anticancer Drugs. 10:1999;375.
10. Konstadoulakis M.M., Antonakis P.T., Tsibloulis B.G., Stathopoulos G.P., Manouras A.P., Mylonaki D.B., Golematis B.X. Cancer Chemother. Pharmacol. 48:2001;417.
11. Ellerhorst J.A., Bedikian A.Y., Smith T.M., Papadopoulos N.E., Plager C., Eton O. Anticancer Drugs. 13:2002;169.
12. Schoffski P., Herr A., Vermorken J.B., Van den Brande J., Beijnen J.H., Rosing H., Volk J., Ganser A., Adank S., Botma H.J., Wanders J. Eur. J. Cancer. 38:2002;807.
13. Schoemaker N.E., Rosing H., Jansen S., Schoffski P., Rizzo J., Schellens J.H., Beijnen J.H. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 775:2002;231.
14. Hinz H.R., Harris N.J., Natelson E.A., Giovanella B.C. Cancer Res. 54:1994;3096.
15. Cao Z., Harris N., Kozielski A., Vardeman D., Stehlin J.S., Giovanella B. J. Med. Chem. 41:1998;31.
16. Pantazis P., Harris N., Mendoza J., Giovanella B. Eur. J. Haematol. 53:1994;246.
17. Pantazis P., Harris N., Mendoza J., Giovanella B. Eur. J. Haematol. 55:1995;211.
18. de Souza P.L., Cooper M.R., Imondi A.R., Myers C.E. Clin. Cancer Res. 3:1997;287.
19. Takimoto C.H., Wright J., Arbuck S.G. Biochim. Biophys. Acta. 1400:1998;107.